Kelly K - Search Results

1

Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials.

Lara PN Jr, Redman MW, Kelly K, Edelman MJ, Williamson SK, Crowley JJ, Gandara DR; Southwest Oncology Group. Lara PN Jr, et al. Among authors: kelly k. J Clin Oncol. 2008 Jan 20;26(3):463-7. doi: 10.1200/JCO.2007.13.0344. J Clin Oncol. 2008. PMID: 18202421 Clinical Trial.

2

New treatment agents for advanced small cell and non-small cell lung cancer.

Bunn PA Jr, Kelly K. Bunn PA Jr, et al. Among authors: kelly k. Semin Oncol. 1995 Jun;22(3 Suppl 6):53-63. Semin Oncol. 1995. PMID: 7597434 Review.

3

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.

Bunn PA Jr, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR, et al. Bunn PA Jr, et al. Among authors: kelly k. J Clin Oncol. 1995 Jul;13(7):1632-41. doi: 10.1200/JCO.1995.13.7.1632. J Clin Oncol. 1995. PMID: 7602352 Clinical Trial.

4

Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.

Kelly K, Crowley JJ, Bunn PA Jr, Hazuka MB, Beasley K, Upchurch C, Weiss GR, Hicks WJ, Gandara DR, Rivkin S, et al. Kelly K, et al. J Clin Oncol. 1995 Dec;13(12):2924-30. doi: 10.1200/JCO.1995.13.12.2924. J Clin Oncol. 1995. PMID: 8523056 Clinical Trial.

5

Overview of the randomized phase III trials in non-small cell lung cancer in North America.

Kelly K. Kelly K. Semin Oncol. 1997 Jun;24(3 Suppl 8):S8-2-S8-5. Semin Oncol. 1997. PMID: 9207308 Review.

6

New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.

Bunn PA Jr, Kelly K. Bunn PA Jr, et al. Among authors: kelly k. Clin Cancer Res. 1998 May;4(5):1087-100. Clin Cancer Res. 1998. PMID: 9607565 Review.

7

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

Wozniak AJ, Crowley JJ, Balcerzak SP, Weiss GR, Spiridonidis CH, Baker LH, Albain KS, Kelly K, Taylor SA, Gandara DR, Livingston RB. Wozniak AJ, et al. Among authors: kelly k. J Clin Oncol. 1998 Jul;16(7):2459-65. doi: 10.1200/JCO.1998.16.7.2459. J Clin Oncol. 1998. PMID: 9667264 Clinical Trial.

8

A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.

Kelly K, Pan Z, Murphy J, Huffman DH, Bunn PA Jr. Kelly K, et al. Clin Cancer Res. 1997 Jul;3(7):1117-23. Clin Cancer Res. 1997. PMID: 9815791 Clinical Trial.

9

The role of single-agent gemcitabine in the treatment of non-small-cell lung cancer.

Kelly K. Kelly K. Ann Oncol. 1999;10 Suppl 5:S53-6. doi: 10.1093/annonc/10.suppl_5.s53. Ann Oncol. 1999. PMID: 10582140 Free article. Review.

10

A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.

Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA Jr. Kelly K, et al. Clin Cancer Res. 1999 Nov;5(11):3419-24. Clin Cancer Res. 1999. PMID: 10589753 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,700 results

Search Page

Filters